Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex

NeuroImage

Volumn 49, Issue 1, 2010, Pages 767-771

  Gallinat, Jürgen ^a   Schubert, Florian ^b   Brühl, Rüdiger ^b   Hellweg, Rainer ^a   Klär, Andreas A ^a   Kehrer, Colin ^a   Wirth, Christoph ^a   Sander, Thomas ^c   Lang, Undine E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Anterior cingulate cortex; BDNF; Brain derived neurotrophic factor; Depression; Genotype; NAA; Plasticity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CREATINE; CREATINE PHOSPHATE; METHIONINE; N ACETYLASPARTIC ACID; VALINE;

ADULT; ALLELE; ARTICLE; CINGULATE GYRUS; FEMALE; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; VOLUNTEER;

ADULT; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; ASPARTIC ACID; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; CHOLINE; CREATINE; FEMALE; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHIONINE; NEURONS; POLYMORPHISM, SINGLE NUCLEOTIDE; VALINE;

EID: 70349973845     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.08.018     Document Type: Article

References (48)

1. Ashburner J., and Friston K. Multimodal image coregistration and partitioning-a unified framework. Neuroimage 6 (1997) 209-217
2. Aydin K., Ucok A., and Guler J. Altered metabolic integrity of corpus callosum among individuals at ultra high risk of schizophrenia and first-episode patients. Biol. Psychiatry 64 (2008) 750-757
3. Baslow M.H., Hrabe J., and Guilfoyle D.N. Dynamic relationship between neurostimulation and N-acetylaspartate metabolism in the human visual cortex: evidence that NAA functions as molecular water pump during visual stimulation. J. Mol. Neurosci. 32 (2007) 235-245
4. Chen J.G., Charles H.C., Barboriak D.P., and Doraiswamy P.M. Magnetic resonance spectroscopy in Alzheimer's disease: focus on N-acetylaspartate. Acta Neurol. Scand. Suppl. 176 (2000) 20-26
5. Clark J.F., Doepke A., Filosa J.A., Wardle R.L., Lu A., Meeker T.J., et al. N-acetylaspartate as a reservoir for glutamate. Med. Hypotheses 67 (2006) 506-512
6. Danielsen E.R., and Henriksen O. Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites. NMR Biomed. 7 (1994) 311-318
7. De Stefano N., Matthews P.M., and Arnold D.L. Reversible decreases in N-acetylaspartate after acute brain injury. Magn. Reson. Med. 34 (1995) 721-727
8. Drevets W.C., Savitz J., and Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 13 (2008) 663-681
9. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
10. Elster C., Schubert F., Link A., Walzel M., Seifert F., and Rinneberg H. Quantitative magnetic resonance spectroscopy: semi-parametric modeling and determination of uncertainties. Magn. Reson. Med. 53 (2005) 1288-1296
11. Ertugrul A., and Uluǧ B. The effect of clozapine on neuroimaging findings in schizophrenia. Psychiatr. Danub. 19 (2007) 367-369
12. Fornito A., Yung A.R., Wood S.J., Phillips L.J., Nelson B., Cotton S., et al. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol. Psychiatry 64 (2008) 758-765
13. Fornito A., Yücel M., Dean B., Wood S.J., and Pantelis C. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr. Bull. 35 (2008) 973-993
14. Gallinat J., and Schubert F. Regional cerebral glutamate concentrations and chronic tobacco consumption. Pharmacopsychiatry 40 (2007) 64-67
15. Gallinat J., Mulert C., Bajbouj M., Herrmann W.M., Schunter J., Senkowski D., et al. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 17 (2002) 110-127
16. Gallinat J., Bajbouj M., Sander T., Schlattmann P., Xu K., Ferro E.F., et al. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol. Psychiatry 54 (2003) 40-48
17. Gallinat J., Ströhle A., Lang U.E., Bajbouj M., Kalus P., Montag C., et al. Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety. Neuroimage 26 (2005) 123-131
18. Ho B.C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., and Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch. Gen. Psychiatry 63 (2006) 731-740
19. Ho B.C., Andreasen N.C., Dawson J.D., and Wassink T.H. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am. J. Psychiatry 164 (2007) 1890-1899
20. Karege F., Vaudan G., Schwald M., Perroud N., and La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 136 (2005) 29-37
21. Kato M., and Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry (2008) 10.1038/mp.2008.116
22. Kreis R. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed. 17 (2004) 361-381
23. Lang U.E., Hellweg R., and Gallinat J. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29 (2004) 795-798
24. Lang U.E., Jockers-Scherübl M.C., and Hellweg R. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J. Neural. Transm. 111 (2004) 387-411
25. Lang U.E., Hellweg R., Kalus P., Bajbouj M., Lenzen K.P., Sander T., et al. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180 (2005) 95-99
26. Lang U.E., Hellweg R., Seifert F., Schubert F., and Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry 62 (2007) 530-535
27. Lang U.E., Puls I., Muller D.J., Strutz-Seebohm N., and Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol. Biochem. 20 (2008) 687-702
28. Lang U.E., Hellweg R., Sander T., and Gallinat J. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol. Psychiatry 14 (2009) 120-122
29. Li S.J., Wang Y., Pankiewicz J., and Stein E.A. Neurochemical adaptation to cocaine abuse: reduction of N-acetyl aspartate in thalamus of human cocaine abusers. Biol. Psychiatry 45 (1999) 1481-1487
30. Mannie Z.N., Norbury R., Murphy S.E., Inkster B., Harmer C.J., and Cowen P.J. Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression. Br. J. Psychiatry 192 (2008) 356-361
31. Miller S.A., Dykes D.D., and Plesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
32. Molina V., Sánchez J., Sanz J., Reig S., Benito C., Leal I., et al. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur. Psychiatry 22 (2007) 505-512
33. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 10 (2005) 208-212
34. Petryshen, T.L., Sabeti, P.C., Aldinger, K.A., B Fry, B., Fan, J.B., Schaffner, S.F. et al., 2009. Population genetic study of the brain-derived neurotrophic factor (BDNF) gene Mol. Psychiatry. doi:10.1038/mp.2009.24.
35. Rango M., Spagnoli D., Tomei G., Bamonti F., Scarlato G., and Zetta L. Central nervous system trans-synaptic effects of acute axonal injury: a 1 H magnetic resonance spectroscopy study. Magn. Reson. Med. 33 (1995) 595-600
36. Schubert F., Gallinat J., Seifert F., and Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 21 (2004) 1762-1771
37. Schulte-Herbrüggen O., Jockers-Scherübl M.C., and Hellweg R. Neurotrophins: from pathophysiology to treatment in Alzheimer's disease. Curr. Alzheimer Res. 5 (2008) 38-44
38. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 (1998) 22-33
39. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., et al. Mol. Psychiatry 7 (2002) 579-593
40. Steen R.G., Hamer R.M., and Lieberman J.A. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30 (2005) 1949-1962
41. Steffens M., Lamina C., Illig T., Bettecken T., Vogler R., Entz P., Suk E.K., et al. SNP-based analysis of genetic substructure in the German population. Hum. Hered. 62 (2006) 20-29
42. Stern A.J., Savostyanova A.A., Goldman A., Barnett A.S., van der Veen J.W., Callicott J.H., et al. Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol. Psychiatry 64 (2008) 856-862
43. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 5 (2000) 293-300
44. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59 (1992) 55-61
45. Witthaus H., Brüne M., Kaufmann C., Bohner G., Ozgürdal S., Gudlowski Y., Heinz A., Klingebiel R., and Juckel G. White matter abnormalities in subjects at ultra high-risk for schizophrenia and first-episode schizophrenic patients. Schizophr. Res. 102 (2008) 141-149
46. Yildiz-Yesiloglu A., and Ankerst D.P. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 969-995
47. Zabala A., Sánchez-González J., Parellada M., Moreno D.M., Reig S., Burdalo M.T., et al. Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis. Psychiatry Res. 156 (2007) 33-42
48. Zetzsche T., Preuss U., Frodl T., Watz D., Schmitt G., Koutsouleris N., et al. In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: new findings and comparison with the literature. Schizophr. Res. 96 (2007) 34-45